Grant ID RP220587
Awarded On September 14, 2022
Title Advanced Protein Therapeutics core
Program Academic Research
Award Mechanism Core Facility Support Awards
Institution/Organization The University of Texas at Austin
Principal Investigator/Program Director Jennifer Maynard
Cancer Sites Brain and Other Nervous System, Breast, Pancreas
Contracted Amount $3,995,180*

*Pending contract negotiation

Lay Summary

Protein therapeutics are the fastest growing pharmaceutical sector and have helped many millions of patients. These therapeutics include antibodies that bind tumor cells to recruit immune responses and enzymes which starve tumors of essential nutrients. Compared with chemotherapies and radiation, proteins are generally safer and less toxic. However, the activities required to discover, engineer, and produce protein therapeutics require specialized skills and resources, which presents barriers that limit the ability of most cancer researchers to translate their research into new therapeutics. Recognizing that over 80 percent of FDA-approved therapies are originally derived from academic resea...

Read More